This is the first and only oral JAK inhibitor indicated for giant cell arteritis, according to the manufacturer AbbVie. Medscape Medical News
Category: News
Luxa to Present Phase 1/2a Clinical and Preclinical Data on RPESC-RPE-4W Therapy for Dry AMD at 2025 ARVO Annual Meeting
FORT LEE, N.J.–(BUSINESS WIRE)–Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing novel adult retinal pigment epithelial stem cell (RPESC) therapies for dry age-related macular degeneration (dry AMD), today announced the…
Red-Light Therapy May Reduce Cone Density in Myopic Children
Medscape Medical News
EyeMD EMR Healthcare Systems, Inc., a Leading Healthcare Technology Provider for Ophthalmologists, Announces Significant Growth Investment from Performant Capital
CHICAGO–(BUSINESS WIRE)–EyeMD EMR Healthcare Systems, Inc., (“EyeMD EMR” or “the Company”), a leading provider of healthcare technology software solutions purpose-built for ophthalmologists and eye care specialists, announced a significant majority g…
Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
GENEVA–(BUSINESS WIRE)–Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
STAAR Surgical Announces Changes to Board of Directors
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced changes to its Board of Directors. The C…
Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics Awarded $8M CIRM Grant to Advance RTx-015 Gene Therapy for Retinitis Pigmentosa
Are You Prescribing Acne Antibiotics Right? Key Tips
Optimize your acne treatment approach with these key tips on using antibiotics properly, combining therapies, and ensuring the best patient outcomes. Medscape Medical News
National Vision Holdings, Inc. Announces First Quarter 2025 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its first quarter 2025 financial results before the market opens on Wednesday, May 7, 2025, and will host a conference call at 8…
Young Women Binge Drinking at Higher Rates Than Men
Young women are binge drinking more than young men. Medscape Medical News
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
LONDON & SEATTLE–(BUSINESS WIRE)– #ophthalmology–Tenpoint Therapeutics, Ltd. (“Tenpoint”), a global, clinical-stage biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that Hen…
Glaukos to Present Multiple Scientific Abstracts at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that i…
STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that it will release financial results f…
xMEMS Labs Powers World’s First AI Sports Glasses with Cowell MEMS Tweeter, Securing Foothold in Booming AI Glasses Market
SANTA CLARA, Calif.–(BUSINESS WIRE)—- $xMEMS #MEMS–xMEMS Labs, Inc., the global leader in solid-state MEMS speaker technology, today announced that its Cowell MEMS tweeter is now shipping in a groundbreaking AI sports glasses product from BleeqUp, …
Stop Smoking Now to Protect Your Vision, Experts Warn
A “meta–meta-analysis” highlights the negative effects of smoking on ocular health, particularly concerning age-related macular degeneration, cataracts, and primary open-angle glaucoma. Medscape Medical News
Neurotech Appoints Beth Marsh as Chief Commercial Officer
CUMBERLAND, R.I.–(BUSINESS WIRE)–Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced the appointment of Beth Marsh as Chief Commercial Officer, effective April …
Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced t…
Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE Recycling and Biotrue Eye Care Recycling …
Aldeyra Therapeutics Appoints Chip Clark to Board of Directors
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the app…
20/20 Onsite Recognized by TITAN Health Awards for Transforming Healthcare Through Patient-Centric, Point-of-Need Ophthalmic Assessments
BOSTON–(BUSINESS WIRE)–20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services – Healthcare.